Page last updated: 2024-10-30

loratadine and Keratoacanthoma

loratadine has been researched along with Keratoacanthoma in 1 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dangoisse, C1
Meyvisch, K1
Ledoux, M1

Other Studies

1 other study available for loratadine and Keratoacanthoma

ArticleYear
Multiple eruptive keratoacanthoma and immunity disorders.
    Dermatology (Basel, Switzerland), 1993, Volume: 186, Issue:4

    Topics: Aged; Antibodies, Antinuclear; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans;

1993